Retina

According to Jeffrey Heier, MD, RGX-314 administered by subretinal injection was well tolerated. In addition, it was associated with dose-dependent increase in ocular protein expression and evidence of clinical benefit.

Nieraj Jain, MD, describes the investigations that led to the recent identification of this drug-related retinal toxicity and described the clinical features that support its diagnosis.